These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 32612493)
1. Bridging the Gap Between Vessels and Nerves in Fabry Disease. Forstenpointner J; Sendel M; Moeller P; Reimer M; Canaan-Kühl S; Gaedeke J; Rehm S; Hüllemann P; Gierthmühlen J; Baron R Front Neurosci; 2020; 14():448. PubMed ID: 32612493 [TBL] [Abstract][Full Text] [Related]
2. Small fiber dysfunction predominates in Fabry neuropathy. Dütsch M; Marthol H; Stemper B; Brys M; Haendl T; Hilz MJ J Clin Neurophysiol; 2002 Dec; 19(6):575-86. PubMed ID: 12488789 [TBL] [Abstract][Full Text] [Related]
3. Functional and structural nerve fiber findings in heterozygote patients with Fabry disease. Torvin Møller A; Winther Bach F; Feldt-Rasmussen U; Rasmussen A; Hasholt L; Lan H; Sommer C; Kølvraa S; Ballegaard M; Staehelin Jensen T Pain; 2009 Sep; 145(1-2):237-45. PubMed ID: 19665302 [TBL] [Abstract][Full Text] [Related]
5. Enzyme replacement therapy improves function of C-, Adelta-, and Abeta-nerve fibers in Fabry neuropathy. Hilz MJ; Brys M; Marthol H; Stemper B; Dütsch M Neurology; 2004 Apr; 62(7):1066-72. PubMed ID: 15079003 [TBL] [Abstract][Full Text] [Related]
6. Cold-evoked potentials in Fabry disease and polyneuropathy. Kersebaum D; Sendel M; Lassen J; Fabig SC; Forstenpointner J; Reimer M; Canaan-Kühl S; Gaedeke J; Rehm S; Gierthmühlen J; Baron R; Hüllemann P Front Pain Res (Lausanne); 2024; 5():1352711. PubMed ID: 38812855 [TBL] [Abstract][Full Text] [Related]
7. Neurological complications in Fabry disease. Dütsch M; Hilz MJ Rev Med Interne; 2010 Dec; 31 Suppl 2():S243-50. PubMed ID: 21211673 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive and differential long-term characterization of the alpha-galactosidase A deficient mouse model of Fabry disease focusing on the sensory system and pain development. Üçeyler N; Biko L; Hose D; Hofmann L; Sommer C Mol Pain; 2016; 12():. PubMed ID: 27145802 [TBL] [Abstract][Full Text] [Related]
9. Sensory-specific peripheral nerve pathology in a rat model of Fabry disease. Waltz TB; Burand AJ; Sadler KE; Stucky CL Neurobiol Pain; 2021; 10():100074. PubMed ID: 34541380 [TBL] [Abstract][Full Text] [Related]
10. Impaired small fiber conduction in patients with Fabry disease: a neurophysiological case-control study. Üçeyler N; Kahn AK; Kramer D; Zeller D; Casanova-Molla J; Wanner C; Weidemann F; Katsarava Z; Sommer C BMC Neurol; 2013 May; 13():47. PubMed ID: 23705943 [TBL] [Abstract][Full Text] [Related]
11. Pain and small-fiber affection in hereditary neuropathy with liability to pressure palsies (HNPP). Dukefoss TT; Kleggetveit IP; Helås T; Jørum E Scand J Pain; 2019 Dec; 20(1):61-68. PubMed ID: 31536037 [TBL] [Abstract][Full Text] [Related]
13. Reduction of podocyte globotriaosylceramide content in adult male patients with Fabry disease with amenable Mauer M; Sokolovskiy A; Barth JA; Castelli JP; Williams HN; Benjamin ER; Najafian B J Med Genet; 2017 Nov; 54(11):781-786. PubMed ID: 28756410 [TBL] [Abstract][Full Text] [Related]
15. Small fibre neuropathy in Fabry disease: a human-derived neuronal Klein T; Grüner J; Breyer M; Schlegel J; Schottmann NM; Hofmann L; Gauss K; Mease R; Erbacher C; Finke L; Klein A; Klug K; Karl-Schöller F; Vignolo B; Reinhard S; Schneider T; Günther K; Fink J; Dudek J; Maack C; Klopocki E; Seibel J; Edenhofer F; Wischmeyer E; Sauer M; Üçeyler N Brain Commun; 2024; 6(2):fcae095. PubMed ID: 38638148 [TBL] [Abstract][Full Text] [Related]
16. Neuropathic symptoms and findings in women with Fabry disease. Laaksonen SM; Röyttä M; Jääskeläinen SK; Kantola I; Penttinen M; Falck B Clin Neurophysiol; 2008 Jun; 119(6):1365-72. PubMed ID: 18387337 [TBL] [Abstract][Full Text] [Related]
17. Changes in Ionic Conductance Signature of Nociceptive Neurons Underlying Fabry Disease Phenotype. Namer B; Ørstavik K; Schmidt R; Mair N; Kleggetveit IP; Zeidler M; Martha T; Jorum E; Schmelz M; Kalpachidou T; Kress M; Langeslag M Front Neurol; 2017; 8():335. PubMed ID: 28769867 [TBL] [Abstract][Full Text] [Related]
18. Vascular dysfunction in the alpha-galactosidase A-knockout mouse is an endothelial cell-, plasma membrane-based defect. Park JL; Whitesall SE; D'Alecy LG; Shu L; Shayman JA Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1156-63. PubMed ID: 18565198 [TBL] [Abstract][Full Text] [Related]
19. No accumulation of globotriaosylceramide in the heart of a patient with the E66Q mutation in the α-galactosidase A gene. Kobayashi M; Ohashi T; Fukuda T; Yanagisawa T; Inomata T; Nagaoka T; Kitagawa T; Eto Y; Ida H; Kusano E Mol Genet Metab; 2012 Dec; 107(4):711-5. PubMed ID: 23146289 [TBL] [Abstract][Full Text] [Related]
20. Severe endothelial dysfunction in the aorta of a mouse model of Fabry disease; partial prevention by N-butyldeoxynojirimycin treatment. Heare T; Alp NJ; Priestman DA; Kulkarni AB; Qasba P; Butters TD; Dwek RA; Clarke K; Channon KM; Platt FM J Inherit Metab Dis; 2007 Feb; 30(1):79-87. PubMed ID: 17189993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]